Search results - 2 results
A Comparative Immunogenicity and Safety Trial of Two Different Schedules of Single-visit Intradermal Rabies Post-exposure Vaccination Following a Single-visit Pre-exposure Vaccination.
adverse events (AE) following primary and/or booster vaccination. RESULTS: ll subjects, except one (99.3%) in each study group, had a rabies antibody titer >0.5 IU /mL on day 7 following the booster ...
Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days.
vaccination and/or booster dose. Results: All subjects in both study groups possessed a rabies antibody titer >0.5 IU /mL on day 7 following the booster dose. Following the booster dose, subjects exposed to ...